Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 2.4B | 2.4B | 2.4B |
Cost of revenue | 1.0B | 1.0B | 1.1B | 1.1B |
Gross profit | 1.2B | 1.4B | 1.3B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 300.2M | 293.9M | 289.2M | 306.5M |
Operating income | 837.0M | 1.0B | 979.9M | 925.7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 36.7M | 35.4M | 29.5M | 13.8M |
Other income expense | — | — | — | — |
Pretax income | 994.6M | 1.0B | 1.0B | 989.9M |
Tax provision | 257.3M | 268.7M | 258.8M | 255.5M |
Net income | 737.4M | 773.0M | 763.1M | 734.4M |
Basic EPS | — | 9.3 | 9.2 | 8.8 |
Diluted EPS | — | 9.3 | 9.2 | 8.8 |
Basic average shares | — | 82.9M | 83.1M | 83.4M |
Diluted average shares | — | 82.9M | 83.1M | 83.5M |
EBITDA | 1.1B | 1.1B | 1.1B | 1.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -2.8M | -2.8M | -2.0M | -2.0M |
Preferred stock dividends | 0 | 0 | 0 | 0 |